Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence (FI_TOXIN)
Effect And Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence
Sponsor: University Hospital, Rouen
A PHASE3 clinical study on Fecal Incontinence, this trial is completed. The trial is conducted by University Hospital, Rouen and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE3
Status: Unknown → Completed
-
Sep 2024 — Feb 2026 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Aug 2019 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Aug 2019 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Rouen
For direct contact, visit the study record on ClinicalTrials.gov .